- Learning about medical tests
- Bilirubin
- Blood count
- Blood gases
- Bone marrow
- Brain scan
- Bronchoscopy
- CD4 cell count
- Computed tomography (CT) scan
- Creatinine clearance
- Dual-energy X-ray absorptiometry (DEXA) scan
- Endoscopy
- Genotypic resistance tests
- Karnofsky score
- Lactate
- Lipid test
- Liver function
- Lumbar puncture
- Lung function tests
- Magnetic resonance imaging (MRI)
- Nerve conduction tests
- Neuro-cognitive tests
- Papanicolaou (Pap) smear
- Phenotypic resistance tests
- Purified protein derivative (PPD) skin tests
- Serology
- Sigmoidoscopy and rectal biopsy
- Specimen culture
- Sputum tests
- Viral load
- X-ray & ultrasound
Purified protein derivative (PPD) skin tests
What they are
These tests involve injecting small amounts of protein from the mycobacteria that cause tuberculosis into the skin. PPD stands for 'purified protein derivative' which tells you that this is completely non-infectious. It is not a vaccine and it should be completely harmless, although there may be an immune reaction after a couple of days, seen as reddening and hardening of the area where the injection was made.
What it means
The aim of the test is to identify people who have recently been exposed to TB or who have active disease. It may be offered to household contacts of anyone identified as having been exposed to active TB. After further tests, treatment may be offered to anyone who shows a strong positive reaction.
Unfortunately, a negative reaction on this test does not prove the absence of TB. Especially among people with HIV, it may instead show that the ability to respond to TB has diminished, even though TB may be present or even causing disease. A further limitation of the test is that some people have some positive reaction as a result of previous BCG vaccination. There is therefore some difference of views among doctors as to the usefulness of this test and practice varies from country to country, just as there are differences in national policies on the use of BCG.
latest aidsmap news
- Microbicide and PrEP potential for anal sex explored further in monkey studies
- ‘Shocking’ rates of adverse events seen with traditional and medical circumcision in Kenya
- Brazil rejects tenofovir patent
- Fibrosis linked to rapid loss of gut CD4 cells after HIV infection
- Poor results using non-medical HIV counsellors to screen for treatment eligibility in Malawi
- Raltegravir may cause temporary worsening of pre-existing depression
- Etravirine (<i>Intelence</i>) approved in Europe for treatment-experienced patients
- Belief in conspiracy theories means less HIV testing in South Africa
- Case report - viral load undetectable in blood, but detectable in semen
- Blood viral load predicts HIV transmission better than semen viral load in small study among MSM
